Show simple item record

dc.contributor.authorSewell, GJ
dc.contributor.authorRoberts, S
dc.contributor.authorKhammo, N
dc.contributor.authorMcDonnell, G
dc.date.accessioned2015-10-27T16:41:25Z
dc.date.available2015-10-27T16:41:25Z
dc.date.issued2006
dc.identifier.issn1078-1552
dc.identifier.issn1477-092X
dc.identifier.urihttp://hdl.handle.net/10026.1/3724
dc.description.abstract

<jats:p> Objective. The aim of this study was to examine the removal and deactivation of cytotoxic contamination from surfaces of a pharmaceutical isolator workstation. </jats:p><jats:p> Methods. Three marker cytotoxic drugs were evaluated in three phases using decontamination technologies currently available in the pharmaceutical and healthcare environments. Phase I investigated the physical removal of contamination by detergents. Phase II and III investigated the effectiveness of detergents and Vaporised Hydrogen Peroxide (VHP®) in degrading cytotoxic drugs, respectively. </jats:p><jats:p> Results. 5-Flurouracil, doxorubicin and cyclophosphamide were removed from a surface by wiping with detergents. VHP® and alkaline detergents caused degradation of doxorubicin. The observed effect with detergent cleaning was pH dependent, but neither of the technologies applied had any effect on the chemical stability of 5-flurouracil and cyclophosphamide under the conditions tested. </jats:p>

dc.format.extent95-104
dc.format.mediumPrint
dc.languageen
dc.language.isoen
dc.publisherSAGE Publications
dc.subjectAntineoplastic Agents
dc.subjectChromatography, High Pressure Liquid
dc.subjectCyclophosphamide
dc.subjectDecontamination
dc.subjectDetergents
dc.subjectDoxorubicin
dc.subjectDrug Therapy
dc.subjectEnvironmental Monitoring
dc.subjectFluorouracil
dc.subjectHumans
dc.subjectHydrogen Peroxide
dc.subjectOccupational Exposure
dc.subjectOncology Service, Hospital
dc.subjectPharmacy Service, Hospital
dc.subjectWorkplace
dc.titleStudies on the decontamination of surfaces exposed to cytotoxic drugs in chemotherapy workstations
dc.typejournal-article
dc.typeArticle
plymouth.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/16984748
plymouth.issue2
plymouth.volume12
plymouth.publication-statusPublished
plymouth.journalJournal of Oncology Pharmacy Practice
dc.identifier.doi10.1177/1078155206070439
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy/UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy MANUAL
plymouth.organisational-group/Plymouth/Research Groups
plymouth.organisational-group/Plymouth/Research Groups/Institute of Health and Community
plymouth.organisational-group/Plymouth/Users by role
dc.publisher.placeEngland
dc.identifier.eissn1477-092X
dc.rights.embargoperiodNot known
rioxxterms.versionofrecord10.1177/1078155206070439
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.typeJournal Article/Review


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV